161 related articles for article (PubMed ID: 26995975)
21. Genetic testing in hereditary melanoma.
Tsao H; Niendorf K
J Am Acad Dermatol; 2004 Nov; 51(5):803-8. PubMed ID: 15523363
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
23. BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
García-Casado Z; Traves V; Bañuls J; Niveiro M; Gimeno-Carpio E; Jimenez-Sanchez AI; Moragón M; Onrubia JA; Oliver V; Kumar R; Nagore E
Br J Dermatol; 2015 Apr; 172(4):1128-31. PubMed ID: 25385688
[No Abstract] [Full Text] [Related]
24. Identification of five chromosomal regions involved in predisposition to melanoma by genome-wide scan in the MeLiM swine model.
Geffrotin C; Crechet F; Le Roy P; Le Chalony C; Leplat JJ; Iannuccelli N; Barbosa A; Renard C; Gruand J; Milan D; Horak V; Tricaud Y; Bouet S; Franck M; Frelat G; Vincent-Naulleau S
Int J Cancer; 2004 May; 110(1):39-50. PubMed ID: 15054867
[TBL] [Abstract][Full Text] [Related]
25. Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).
Visser M; van der Stoep N; Gruis N
Fam Cancer; 2019 Apr; 18(2):267-271. PubMed ID: 30659395
[No Abstract] [Full Text] [Related]
26. Toward a molecular classification of melanoma.
Fecher LA; Cummings SD; Keefe MJ; Alani RM
J Clin Oncol; 2007 Apr; 25(12):1606-20. PubMed ID: 17443002
[TBL] [Abstract][Full Text] [Related]
27. Genetic alterations in melanocytic tumors.
Takata M; Saida T
J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
[TBL] [Abstract][Full Text] [Related]
28. Genetic variations of patients with familial or multiple melanoma in Southern Brazil.
Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339
[TBL] [Abstract][Full Text] [Related]
29. Main roads to melanoma.
Palmieri G; Capone M; Ascierto ML; Gentilcore G; Stroncek DF; Casula M; Sini MC; Palla M; Mozzillo N; Ascierto PA
J Transl Med; 2009 Oct; 7():86. PubMed ID: 19828018
[TBL] [Abstract][Full Text] [Related]
30. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
Itin PH; Fistarol SK
Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
[TBL] [Abstract][Full Text] [Related]
31. Genetics of melanoma predisposition.
Lin J; Hocker TL; Singh M; Tsao H
Br J Dermatol; 2008 Aug; 159(2):286-91. PubMed ID: 18547303
[TBL] [Abstract][Full Text] [Related]
32. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
33. Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.
Thomas NE; Kanetsky PA; Edmiston SN; Alexander A; Begg CB; Groben PA; Hao H; Busam K; Ollila DW; Berwick M; Conway K
J Invest Dermatol; 2010 May; 130(5):1463-5. PubMed ID: 20043015
[No Abstract] [Full Text] [Related]
34. Melanoma susceptibility genes.
Newton-Bishop J; Gruis N
Melanoma Res; 2010 Jun; 20(3):161-2. PubMed ID: 20442621
[No Abstract] [Full Text] [Related]
35. Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation.
Veinalde R; Ozola A; Azarjana K; Molven A; Akslen LA; Doniņa S; Proboka G; Cēma I; Baginskis A; Pjanova D
Melanoma Res; 2013 Jun; 23(3):221-6. PubMed ID: 23546221
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
Bergman W; Gruis NA
Arch Dermatol; 2007 Apr; 143(4):525-6. PubMed ID: 17438187
[No Abstract] [Full Text] [Related]
37. Genetic predisposition to melanoma.
Hawkes JE; Truong A; Meyer LJ
Semin Oncol; 2016 Oct; 43(5):591-597. PubMed ID: 27899192
[TBL] [Abstract][Full Text] [Related]
38. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
39. Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum.
Wang Y; Tan XH; DiGiovanna JJ; Lee CC; Stern JB; Raffeld M; Jaffe ES; Kraemer KH
J Invest Dermatol; 2010 Apr; 130(4):1188-91. PubMed ID: 19956187
[No Abstract] [Full Text] [Related]
40. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
